Repligen | RGEN - 当期純利益





当期純利益 変化する 日付
Agilent USD 339M 34M 2026-03
Align Technology USD 108.29M 4.48M 2026-06
Bio Techne USD 51.05M 13.04M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Bruker USD 3.5M 22.5M 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Danaher USD 870M 159M 2026-06
Dentsply International USD -10M 136M 2026-03
General Electric Aerospace USD 2.37B 466M 2026-06
Henry Schein USD 107M 6M 2026-03
Illumina USD 207M 73M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Repligen USD 5.01M 3.32M 2026-06
Revvity USD 40.72M 57.65M 2026-03
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Waters USD -72M 297.21M 2026-03
West Pharmaceutical Services USD 154M 15.2M 2026-06